Aadi Bioscience (NASDAQ:AADI) Releases Earnings Results, Beats Expectations By $0.17 EPS

Aadi Bioscience (NASDAQ:AADI – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.54) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.71) by $0.17, Zacks reports. The business had revenue of $6.18 million for the quarter, compared to analyst estimates of $6.33 million. Aadi Bioscience had a […]

Leave a Reply

Your email address will not be published.

Previous post JPMorgan Chase & Co. Raises Myriad Genetics (NASDAQ:MYGN) Price Target to $20.00
Next post Csenge Advisory Group Purchases 1,866 Shares of Morgan Stanley (NYSE:MS)